Browse > Article
http://dx.doi.org/10.15324/kjcls.2022.54.1.9

Protective Effect of Curcumin on Dextran Sulfate Sodium-Induced Ulcerative Colitis in Obese Mice  

Park, Ho (Department of Clinical Laboratory Science, Wonkwang Health Science University)
Publication Information
Korean Journal of Clinical Laboratory Science / v.54, no.1, 2022 , pp. 9-14 More about this Journal
Abstract
Ulcerative colitis is a disease that causes inflammation in the mucosal or submucosal layer of the colon. Previous studies have reported that obesity increases the prevalence of ulcerative colitis and aggravates the progression. This study was therefore undertaken to investigate whether curcumin inhibits the progression of ulcerative colitis caused by obesity. Mice were bred on a high-fat diet to induce obesity, and curcumin was administered with the high-fat diet to confirm the anti-inflammatory effect. To induce ulcerative colitis, dextran sulfate sodium (DSS) was administered orally, and clinical symptoms of colitis were subsequently observed. For histological evaluation of curcumin, the colon, liver and abdominal fat tissue samples were prepared and analyzed by hematoxylin and eosin (H&E) and Alcian blue-periodic acid-Schiff (PAS) staining. Our results confirm that consumption of curcumin resulted in decreasing the score of the disease activity index, and inhibited shortening of the colon length. In addition, inflammatory cell infiltration and mucosal damage were inhibited in the colon tissue of ulcerative colitis exacerbated by obesity. We further confirmed that exposure to curcumin significantly reduced the steatosis area of the liver and adipocytes of abdominal fat. In conclusion, we believe that curcumin can be applied as a therapeutic agent to treat ulcerative colitis, by inhibiting the progression of colitis caused by obesity.
Keywords
Curcumin; Dextran sulfate sodium; Inflammation; Obesity; Ulcerative colitis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. Lancet. 2017;389:1756-1770. https://doi.org/10.1016/S0140-6736(16)32126-2   DOI
2 Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4:807-818. https://doi.org/10.1021/mp700113r   DOI
3 Wang J, Zhang C, Guo C, Li X. Chitosan ameliorates DSS-induced ulcerative colitis mice by enhancing intestinal barrier function and improving microflora. Int J Mol Sci. 2019;20:5751. https://doi.org/10.3390/ijms20225751   DOI
4 Li K, Marano C, Zhang H, Yang F, Sandborn WJ, Sands BE, et al. Relationship between combined histologic and endoscopic end-points and efficacy of ustekinumab treatment in patients with ulcerative colitis. Gastroenterology. 2020;159:2052-2064. https://doi.org/10.1053/j.gastro.2020.08.037   DOI
5 Li X, Wei X, Sun Y, Du J, Li X, Xun Z, et al. High-fat diet promotes experimental colitis by inducing oxidative stress in the colon. Am J Physiol Gastrointest Liver Physiol. 2019;317:453-462. https://doi.org/10.1152/ajpgi.00103.2019   DOI
6 Wei M, Gao X, Liu L, Li Z, Wan Z, Dong Y, et al. Visceral adipose tissue derived exosomes exacerbate colitis severity via pro-inflammatory miRNAs in high fat diet fed mice. ACS Nano. 2020;14:5099-5110. https://doi.org/10.1021/acsnano.0c01860   DOI
7 Rogler G. Chronic ulcerative colitis and colorectal cancer. Cancer Lett. 2014;345:235-241. https://doi.org/10.1016/j.canlet.2013.07.032   DOI
8 Singh S, Dulai PS, Zarrinpar A, Ramamoorthy S, Sandborn WJ. Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes. Nat Rev Gastroenterol Hepatol. 2017;14: 110-121. https://doi.org/10.1038/nrgastro.2016.181   DOI
9 Schulz MD, Atay C, Heringer J, Romrig FK, Schwitalla S, Aydin B, et al. High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity. Nature. 2014;514:508-512. https://doi.org/10.1038/nature13398   DOI
10 Kotha RR, Luthria DL. Curcumin: biological, pharmaceutical, nutraceutical, and analytical aspects. Molecules. 2019;24:2930. https://doi.org/10.3390/molecules24162930   DOI
11 Chassaing B, Aitken JD, Malleshappa M, Vijay-Kumar M. Dextran sulfate sodium (DSS)-induced colitis in mice. Curr Protoc Immunol. 2014;104:1-15. https://doi.org/10.1002/0471142735. im1525s104   DOI
12 van der Heijden RA, Sheedfar F, Morrison MC, Hommelberg PP, Kor D, Kloosterhuis NJ, et al. High-fat diet induced obesity primes inflammation in adipose tissue prior to liver in C57BL/6j mice. Aging (Albany NY). 2015;7:256-268. https://doi.org/10.18632/aging.100738   DOI
13 Wei SC, Sollano J, Hui YT, Yu W, Santos Estrella PV, Llamado LJQ, et al. Epidemiology, burden of disease, and unmet needs in the treatment of ulcerative colitis in Asia. Expert Rev Gastroenterol Hepatol. 2021;15:275-289. https://doi.org/10.1080/17474124.2021.1840976   DOI
14 Kucharzik T, Koletzko S, Kannengiesser K, Dignass A. Ulcerative colitis-diagnostic and therapeutic algorithms. Dtsch Arztebl Int. 2020;117:564-574. https://doi.org/10.3238/arztebl.2020.0564   DOI
15 Chin KY. The spice for joint inflammation: anti-inflammatory role of curcumin in treating osteoarthritis. Drug Des Devel Ther. 2016;10:3029-3042. https://doi.org/10.2147/DDDT.S117432   DOI